NASDAQ:CRSP
CRISPR Therapeutics AG
- Stock
locale
Switzerland
market
STOCKSindustry
Biotechnologywebsite
www.crisprtx.comipo date
Oct 19, 2016
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA. The company has a portfolio of t...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus